Emory University team explores promising new therapy for childhood leukemia with fewer toxic effects
- 1 minute ago
- 1 min read
This agent is more like a lock-and-key approach aimed at the biology driving the leukemia itself. The hope is not just survival, but a better life after survival, because for children, beating cancer isn't the end of the story.


Comments